Treatment with the angiotensin II type 1 receptor antagonist candesartan does not reduce recurrence rate of atrial fibrillation after electrical cardioversion

被引:0
|
作者
Tveit, A.
Grundvold, I.
Seljeflot, I.
Abdelnoor, M.
Arnesen, H.
Smith, P.
机构
[1] Asker & Baerum Hosp, Rud, Norway
[2] Ullevaal Univ Hosp, Oslo, Norway
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:46 / 46
页数:1
相关论文
共 50 条
  • [1] Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion
    Tveit, Arnljot
    Seljeflot, Ingebjorg
    Grundvold, Irene
    Abdelnoor, Michael
    Arnesen, Harald
    Smith, Pal
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 131 (02) : 234 - 239
  • [2] Angiotensin II type 1 receptor antagonist prevents electrical remodeling in atrial fibrillation
    Nakashima, H
    Kumagai, K
    Gondo, N
    Urata, H
    Ideishi, M
    Arakawa, K
    CIRCULATION, 1999, 100 (18) : 11 - 11
  • [3] Dabigatran to reduce recurrence of atrial fibrillation after successful electrical cardioversion
    Obst, C.
    Roithinger, F. X.
    Fiedler, L.
    Schoenbauer, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (SUPPL 1) : S62 - S63
  • [4] Dabigatran to reduce recurrence of atrial fibrillation after successful electrical cardioversion
    Obst, C.
    Roithinger, F. X.
    Fiedler, L.
    Schoenbauer, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 : S62 - S63
  • [5] Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation
    Kumagai, K
    Nakashima, H
    Urata, H
    Gondo, N
    Arakawa, K
    Saku, K
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) : 2197 - 2204
  • [6] Heart rate variability and recurrence of atrial fibrillation after electrical cardioversion
    Vikman, S
    Mäkikallio, TH
    Yli-Mäyry, S
    Nurmi, M
    Airaksinen, KEJ
    Huikuri, HV
    ANNALS OF MEDICINE, 2003, 35 (01) : 36 - 42
  • [7] Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion
    Lombardi, F
    Colombo, A
    Basilico, B
    Ravaglia, R
    Garbin, M
    Vergani, D
    Battezzati, PM
    Fiorentini, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) : 157 - 162
  • [8] No effect of angiotensin II type 1 receptor blockade on markers of inflammation in patients undergoing electrical cardioversion for atrial fibrillation
    Tveit, A.
    Grundvold, I.
    Seljeflot, I.
    Abdelnoor, M.
    Arnesen, H.
    Smith, P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 46 - 46
  • [9] Inhibition of angiotensin II type 1 receptors reduces atrial stunning and spontaneous echo contrast after electrical cardioversion of atrial fibrillation
    Goette, Andreas
    Schotten, Ulrich
    EUROPEAN HEART JOURNAL, 2006, 27 (17) : 2034 - 2035
  • [10] Analysis of heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion
    Vaiciulyte, R
    Losinskiene, L
    FRONTIERS IN CORONARY ARTERY DISEASE, 2003, : 305 - 307